FOLFIRINOX an option in colorectal cancer with liver metastases Clinical study 02 February 2013 Pages: 18 - 18
Paclitaxel, epirubicin, carboplatin combo for endometrial cancer Clinical study 02 February 2013 Pages: 18 - 18
Terbinafine takes on griseofulvin for tinea in children Clinical study 02 February 2013 Pages: 18 - 18
EMEA recommends restricting use of moxifloxacin, norfloxacin News item 02 February 2013 Pages: 19 - 19
The risk of developing cancer is not increased among patients who received contaminated Viracept [nelfinavir], Media release 02 February 2013 Pages: 20 - 20
US FDA advisory committee recommends tocilizumab for RA. Media release 02 February 2013 Pages: 20 - 20
Alprostadil [NexMed] received a non-approvable letter from the US FDA Media release 02 February 2013 Pages: 21 - 21
Cetuximab [Erbitux; Merck] receives EU approval for broader use in colon cancer. Media release 02 February 2013 Pages: 21 - 21
EU grants orphan drug status for α-1 antitrypsin (AAT) to treat congenital AAT deficiency. Media release 02 February 2013 Pages: 21 - 21
Health Canada approves abatacept for juvenile idiopathic arthritis. Media release 02 February 2013 Pages: 21 - 21
Satraplatin EU marketing authorisation application to be withdrawn. Media release 02 February 2013 Pages: 22 - 22
Ty Pennington announces launch of lisdexamfetamine for adult ADHD in US. Media release 02 February 2013 Pages: 22 - 22
UCB receives not-approvable letter from US FDA for lacosamide. Media release 02 February 2013 Pages: 22 - 22